R
Atrium Therapeutics, Inc.
RNA · NASDAQ · Healthcare · 220M
Price · close
$13.20
-2.08% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.1×
Enterprise value / EBITDAEV/EBITDA
0.2×
Free cash flow yieldFCF yield
-16.9%
Return on equityROE
-37.0%
Operating margin
-412.6%
Net debt / EBITDAbalance-sheet strength
3.5×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.